Cargando…
Anti-Tumor Effects of Metformin in Animal Models of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
BACKGROUND: Several studies have reported that metformin can reduce the risk of hepatocellular carcinoma (HCC) in diabetes patients. However, the direct anti-HCC effects of metformin have hardly been studied in patients, but have been extensively investigated in animal models of HCC. We therefore pe...
Autores principales: | Li, Juan, Hernanda, Pratika Y., Bramer, Wichor M., Peppelenbosch, Maikel P., van Luijk, Judith, Pan, Qiuwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451077/ https://www.ncbi.nlm.nih.gov/pubmed/26030161 http://dx.doi.org/10.1371/journal.pone.0127967 |
Ejemplares similares
-
Tumor promotion through the mesenchymal stem cell compartment in human hepatocellular carcinoma
por: Hernanda, Pratika Y., et al.
Publicado: (2013) -
Direct‐acting antiviral agents for liver transplant recipients with recurrent genotype 1 hepatitis C virus infection: Systematic review and meta‐analysis
por: Liu, Jiaye, et al.
Publicado: (2019) -
Estimating Global Epidemiology of Low-Pathogenic Human Coronaviruses in Relation to the COVID-19 Context
por: Li, Pengfei, et al.
Publicado: (2020) -
The global epidemiology of hepatitis E virus infection: A systematic review and meta‐analysis
por: Li, Pengfei, et al.
Publicado: (2020) -
Factors associated with ethnical disparity in overall survival for patients with hepatocellular carcinoma
por: Li, Juan, et al.
Publicado: (2017)